The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 12, 2019
Filed:
Nov. 11, 2016
Applicant:
Daewoong Pharmaceutical Co., Ltd., Gyeonggi-do, KR;
Inventors:
Hyung-Geun Lee, Gyeonggi-do, KR;
Il-Hwan Kim, Chungcheongbuk-do, KR;
Myunggi Jung, Gyeonggi-do, KR;
Hyo Shin Kim, Incheon, KR;
Chun Ho Lee, Seoul, KR;
Sun Ah Jun, Gyeonggi-do, KR;
Ji Sung Yoon, Gyeonggi-do, KR;
Sung-Young Kim, Gyeonggi-do, KR;
Assignee:
Daewoong Pharmaceutical Co., Ltd., Gyeonggi-do, KR;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/18 (2006.01); C07C 311/21 (2006.01); C07D 417/12 (2006.01); A61K 31/427 (2006.01); A61K 31/497 (2006.01); C07D 417/14 (2006.01); C07D 277/52 (2006.01);
U.S. Cl.
CPC ...
C07D 417/12 (2013.01); A61K 31/427 (2013.01); A61K 31/497 (2013.01); C07D 277/52 (2013.01); C07D 417/14 (2013.01);
Abstract
The invention relates to a compound represented by Chemical Formula 1, below, a pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising the compound or salt. The compound of the invention or pharmaceutically acceptable salts thereof can be used for the prevention or treatment of sodium channel blocker-related diseases.